Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
As of: Sep 4, 2026 · 1:39 PM EDT

Compugen (CGEN) Income towards Parent Company (2009 - 2026)

Compugen (CGEN) posted quarterly Income towards Parent Company of $7.7 million for Q1 2026, up 7.59% year-over-year from $7.1 million in Q1 2025, and down 86.5% on a QoQ basis from $56.7 million in Q4 2025.

Analysis

Compugen (CGEN) Income towards Parent Company (2009 - 2026) Analysis & Trends

Compugen has reported Income towards Parent Company for 18 years, with the latest figure at $7.7 million in Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at $7.7 million, up 7.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.9 million (up 772.34% YoY), and the FY2025 annual result was $35.3 million, up 348.35% from the prior year.
  • Income towards Parent Company eased to $7.7 million in Q1 2026, from $56.7 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $56.7 million in Q4 2025 and troughed at -$28.0 million in Q2 2023.
  • A 5-year average of $1.4 million and a median of -$3.1 million in 2022 frame the typical range for Income towards Parent Company.
  • The widest annual swing landed in 2023, when Income towards Parent Company tumbled 198.03%; it then jumped 1027.53% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at -$3.1 million in 2022, then jumped by 414.13% to $9.7 million in 2023, then slumped by 162.98% to -$6.1 million in 2024, then jumped by 1027.53% to $56.7 million in 2025, then sank by 86.5% to $7.7 million in 2026.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were $7.7 million in Q1 2026, $56.7 million in Q4 2025, and -$6.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Compugen 241.97 Mn 156.35 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.31 Mn
Mar 31, 2026 7.66 Mn
Dec 31, 2025 56.74 Mn
Sep 30, 2025 -6.90 Mn
Jun 30, 2025 -21.61 Mn
Mar 31, 2025 7.12 Mn
Dec 31, 2024 -6.12 Mn
Sep 30, 2024 10.28 Mn
Jun 30, 2024 -16.62 Mn
Mar 31, 2024 7.26 Mn
Dec 31, 2023 9.79 Mn
Sep 30, 2023 -9.85 Mn
Jun 30, 2023 -28.00 Mn
Mar 31, 2023 9.31 Mn
Dec 31, 2022 -3.03 Mn
Sep 30, 2022 -11.75 Mn
Jun 30, 2022 28.56 Mn
Mar 31, 2022 -9.71 Mn
Dec 31, 2021 -6.63 Mn
Sep 30, 2021 -8.18 Mn